Maturity onset diabetes of the young historical perspective
|
Maturity onset diabetes of the young Microchapters |
|
Differentiating Maturity onset diabetes of the young from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Maturity onset diabetes of the young historical perspective On the Web |
|
American Roentgen Ray Society Images of Maturity onset diabetes of the young historical perspective |
|
FDA on Maturity onset diabetes of the young historical perspective |
|
CDC on Maturity onset diabetes of the young historical perspective |
|
Maturity onset diabetes of the young historical perspective in the news |
|
Blogs on Maturity onset diabetes of the young historical perspective |
|
Directions to Hospitals Treating Maturity onset diabetes of the young |
|
Risk calculators and risk factors for Maturity onset diabetes of the young historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
The term MODY dates back to 1964, when diabetes mellitus was considered to have two main forms: juvenile-onset and maturity-onset, which roughly corresponded to what we now call type 1 and type 2. MODY was originally applied to any child or young adult who had persistent, asymptomatic hyperglycemia without progression to diabetic ketoacidosis or ketoacidosis. In retrospect we can now recognize that this category covered a heterogeneous collection of disorders which included cases of dominantly inherited diabetes (the topic of this article, still called MODY today), as well as cases of what we would now call type 2 diabetes occurring in childhood or adolescence, and a few even rarer types of hyperglycemia (e.g., mitochondrial diabetes or mutant insulin). Many of these patients were treated with sulfonylureas with varying degrees of success.
By the 1990s, as the understanding of the pathophysiology of diabetes has improved, the concept and usage of "MODY" have become refined and narrower. It is now used as a synonym for dominantly inherited, monogenic defects of insulin secretion occurring at any age, and no longer includes any forms of type 2 diabetes.